Dyslipidemia in Newly Diagnosed Diabetic Patients With or Without Micro Albuminuria
DOI:
https://doi.org/10.51985/JBUMDC2019049Keywords:
Dyslipidemia, Micro albuminuria, Newly diagnosed diabetic patients.Abstract
Objective: To assess the dyslipidemia in newly diagnosed diabetic patients and compare it with or without micro albuminuria.
Study Design and Setting: Cross-sectional study at Department of Medicine, Military Hospital Rawalpindi from 01 March
2015 to 31 August 2015.
Methodology: A total of 150 patients who fulfilled the inclusion criteria were included after taking informed consent and
approval from hospital ethical committee. Blood sample was obtained from each patient and samples were sent to hospital
laboratory and reports were assessed by pathologist. Presence or absence of microalbuminuria, trigiyceridemia (200-499
mg/dl), raised LDL-C (>160 mg/dl) and decreased HDL-C (<40 mg/dl) were noted by researcher himself on a pre-designed
performa. The collected data was analyzed statistically by using SPSS version 12.Quantitative variables like age, TG, LDL
HDL levels were presented in form of mean ± S.D. Qualitative variables like gender, diabetes mellitus, micro albuminuria
and dyslipidemia were presented as frequencies and percentages. Chi-square test was applied to find association between
dyslipidemia and micro albuminuria. P value = 0.05 was considered as statistically significant.
Results: Mean ± SD of age was 47.97±7.08 years. Out of 150 patients 60% were male and 40% were female. Dyslipidemia
was found in 42% patients. Highly significant association was found between dyslipidemia and micro albuminuria, i.e.
(P=0.0001).
Conclusion: The frequency of dyslipidemia among newly diagnosed diabetic patients with micro albuminuria was
significantly higher than in subjects without micro albuminuria.
References
Herath H, Weerasinghe N, Dias H, Weerarathna T. Knowledge,
attitude and practice related to diabetes mellitus among the
general public in Galle district in Southern Sri Lanka: a pilot
study. BMC Public Health. 2017;17(1).
Sami W, Ansari T, Butt NS, Ab Hamid MR. Effect of diet on
type 2 diabetes mellitus: A review. International journal of
health sciences. 2017;11(2):65.
Previti E, Salinari S, Bertuzzi A, Capristo E, Bornstein S,
Mingrone G. Glycemic control after metabolic surgery: a
Granger causality and graph analysis. American Journal of
Physiology - Endocrinology And Metabolism. 2017;:ajpendo.
2017.
World Health Organization. Global report on diabetes [Internet].
Geneva: World Health Organization; 2016. Available from:
http://www.who.int/diabetes/global-report/en/
Akhtar S, Khan Z, Rafiq M, Khan A. Prevalence of Type II
diabetes in District Dir Lower in Pakistan. Pakistan Journal of
Medical Sciences. 2016;32(3).
Abdel-Gayoum AG. The effect of glycemic control in type 2
diabetic patients with diabetes-related dyslipidemia. Saudi
Med J. 2004;25:207-11.
Prasad R, Groop L. Genetics of Type 2 Diabetes—Pitfalls and
Possibilities. Genes. 2015;6(4):87-123.
Cantley J, Ashcroft F. Q&A: insulin secretion and type 2
diabetes: why do â-cells fail?. BMC Biology. 2015;13(1).
Afsar B, Elsurer R. The independent relationship between
creatinine clearance, micro albuminuria and circadian blood
pressure levels in newly diagnosed essential hypertensive and
type 2 diabetic patients. J Diabetes Complications. 2012;26:531-
Adar T, Lysy J. Pseudodyslipidemia: are we over-treating
dyslipidemia in diabetic patients with undiagnosed
gastroparesis? Endocrine. 2014;45:26-7.
Agaba EI, Agaba PA, Puepet FH. Prevalence of micro
albuminuria in newly diagnosed type 2 diabetic patients in Jos
Nigeria. Afr J Med Med Sci. 2004;33:19-22.
Chen SC, Tseng CH. Dyslipidemia, kidney disease, and
cardiovascular disease in diabetic patients. Rev Diabet Stud.
;10:88-100.
Chen SC, Tseng CH. Dyslipidemia, kidney disease, and
cardiovascular disease in diabetic patients. The review of
diabetic studies: RDS. 2013;10(2-3):88.
Harris MI, Eastman RC. Early detection of undiagnosed diabetes
mellitus: a US perspective. Diabetes/metabolism research and
reviews. 2000;16:230-6.
Huang JW, Lien YC, Yang CY, Liu KL, Wu CF, Yen CJ, et
al. Osteoprotegerin, inflammation and dyslipidemia are
associated with abdominal aortic calcification in non-diabetic
patients on peritoneal dialysis. NutrMetabCardiovasc Dis.
;24:236-42.
Jisieike-Onuigbo NN, Unuigbe EI, Kalu OA, Oguejiofor CO,
Onuigbo PC. Prevalence of dyslipidemia among adult diabetic
patients with overt diabetic nephropathy in Anambra state
south-east Nigeria. Niger J ClinPract. 2011;14:171-5.
PascualFuster V, Ruiz Olivar E, Pinto Sala X. [Patient's care
and management of dyslipidemia in type 2 diabetic patients
in the clinical practice in Spain: The LIPEDIA study].
ClinInvestigArterioscler. 2015;27:45-56.
Goff DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS,
Tsai MY, et al. Dyslipidemia prevalence, treatment, and control
in the multi-ethnic study of atherosclerosis (MESA) gender,
ethnicity, and coronary artery calcium. Circulation.
;113:647-56.
Xu Y, Bao Q, He B, Pan Y, Zhang R, Mao X, et al. Association
of angiotensin I converting enzyme, angiotensin II type 1
receptor and angiotensin I converting enzyme 2 gene
polymorphisms with the dyslipidemia in type 2 diabetic
patients of Chinese Han origin. J Endocrinol Invest.
;35:378-83.
Yadav D, Mishra M, Tiwari A, Bisen PS, Goswamy HM,
Prasad GB. Prevalence of dyslipidemia and hypertension in
Indian type 2 diabetic patients with metabolic syndrome and
its clinical significance. Osong Public Health Res Perspect.
;5:169-75.
Haffner SM. American diabetes association. Dyslipidemia
management in adults with diabetes. 2004.
Bays HE, Chapman R, Grandy S. The relationship of body
mass index to diabetes mellitus, hypertension and
dyslipidaemia: comparison of data from two national surveys.
International journal of clinical practice. 2007;61:737-47.
Zimmet PZ, Alberti G. The Metabolic Syndrome: Perhaps an
Etiologic Mystery but Far From a Myth—Where Does the
International Diabetes Federation Stand? Medscape Diabetes
& Endocrinology. 2005;8.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga
FA. Association between insulin resistance and the
development of cardiovascular disease. Cardiovascular
diabetology. 2018;17(1):122.
Nielsen JB, Leppin A, e Gyrd-Hansen D, Jarbøl DE,
Søndergaard J, Larsen PV. Barriers to lifestyle changes for
prevention of cardiovascular disease–a survey among 40–60-
year old Danes. BMC cardiovascular disorders.
;17(1):245.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Naimatullah Khan, Javed Iqbal Khan, Tariq Mehmood, Aqeel Peter
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
